Lipoatrophy

10 clinical trials · Condition

Record	Firm	Date
Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. (NCT04860063)	Hospital Civil de Guadalajara	2021-04-01
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) (NCT02914886)	Kinderkrankenhaus auf der Bult	2016-09-01
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers (NCT02647853)	Topokine Therapeutics, Inc.	2014-10-01
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells (NCT01828723)	Antria	2013-04-01
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients (NCT00978237)	Juan A. Arnaiz	2009-10-01
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy (NCT00307164)	National Institute of Allergy and Infectious Diseases (NIAID)	2006-09-01
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. (NCT00139178)	Danish HIV Research Group	2004-03-01
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy (NCT00312832)	Hospital Clinic of Barcelona	2004-01-01

Every clearance here is in the API, with alerts when new ones post.